Literature DB >> 9744270

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.

R T Nolte1, G B Wisely, S Westin, J E Cobb, M H Lambert, R Kurokawa, M G Rosenfeld, T M Willson, C K Glass, M V Milburn.   

Abstract

The peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is a ligand-dependent transcription factor that is important in adipocyte differentiation and glucose homeostasis and which depends on interactions with co-activators, including steroid receptor co-activating factor-1 (SRC-1). Here we present the X-ray crystal structure of the human apo-PPAR-gamma ligand-binding domain (LBD), at 2.2 A resolution; this structure reveals a large binding pocket, which may explain the diversity of ligands for PPAR-gamma. We also describe the ternary complex containing the PPAR-gamma LBD, the antidiabetic ligand rosiglitazone (BRL49653), and 88 amino acids of human SRC-1 at 2.3 A resolution. Glutamate and lysine residues that are highly conserved in LBDs of nuclear receptors form a 'charge clamp' that contacts backbone atoms of the LXXLL helices of SRC-1. These results, together with the observation that two consecutive LXXLL motifs of SRC-1 make identical contacts with both subunits of a PPAR-gamma homodimer, suggest a general mechanism for the assembly of nuclear receptors with co-activators.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9744270     DOI: 10.1038/25931

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  464 in total

1.  Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4alpha1.

Authors:  F M Sladek; M D Ruse; L Nepomuceno; S M Huang; M R Stallcup
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

2.  Transcriptional activation by NF-kappaB requires multiple coactivators.

Authors:  K A Sheppard; D W Rose; Z K Haque; R Kurokawa; E McInerney; S Westin; D Thanos; M G Rosenfeld; C K Glass; T Collins
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 3.  Modulating nuclear receptor function: may the phos be with you.

Authors:  D Shao; M A Lazar
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

4.  Rational discovery of novel nuclear hormone receptor antagonists.

Authors:  M Schapira; B M Raaka; H H Samuels; R Abagyan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

5.  Isolation of a novel family of C(2)H(2) zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors.

Authors:  D Avram; A Fields; K Pretty On Top; D J Nevrivy; J E Ishmael; M Leid
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

6.  The orphan nuclear receptor Ear-2 is a negative coregulator for thyroid hormone nuclear receptor function.

Authors:  X G Zhu; K S Park; M Kaneshige; M K Bhat; Q Zhu; C N Mariash; P McPhie; S Y Cheng
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

7.  Mechanism of corepressor binding and release from nuclear hormone receptors.

Authors:  L Nagy; H Y Kao; J D Love; C Li; E Banayo; J T Gooch; V Krishna; K Chatterjee; R M Evans; J W Schwabe
Journal:  Genes Dev       Date:  1999-12-15       Impact factor: 11.361

8.  The alpha-helical FXXPhiPhi motif in p53: TAF interaction and discrimination by MDM2.

Authors:  M Uesugi; G L Verdine
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

9.  Molecular determinants of nuclear receptor-corepressor interaction.

Authors:  V Perissi; L M Staszewski; E M McInerney; R Kurokawa; A Krones; D W Rose; M H Lambert; M V Milburn; C K Glass; M G Rosenfeld
Journal:  Genes Dev       Date:  1999-12-15       Impact factor: 11.361

10.  Determinants of CoRNR-dependent repression complex assembly on nuclear hormone receptors.

Authors:  X Hu; Y Li; M A Lazar
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.